Barriers to colorectal cancer screening in community health centers: a qualitative study

Karen E Lasser, John Z Ayanian, Robert H Fletcher, Mary-Jo DelVecchio Good, Karen E Lasser, John Z Ayanian, Robert H Fletcher, Mary-Jo DelVecchio Good

Abstract

Background: Colorectal cancer screening rates are low among disadvantaged patients; few studies have explored barriers to screening in community health centers. The purpose of this study was to describe barriers to/facilitators of colorectal cancer screening among diverse patients served by community health centers.

Methods: We identified twenty-three outpatients who were eligible for colorectal cancer screening and their 10 primary care physicians. Using in-depth semi-structured interviews, we asked patients to describe factors influencing their screening decisions. For each unscreened patient, we asked his or her physician to describe barriers to screening. We conducted patient interviews in English (n = 8), Spanish (n = 2), Portuguese (n = 5), Portuguese Creole (n = 1), and Haitian Creole (n = 7). We audiotaped and transcribed the interviews, and then identified major themes in the interviews.

Results: Four themes emerged: 1) Unscreened patients cited lack of trust in doctors as a barrier to screening whereas few physicians identified this barrier; 2) Unscreened patients identified lack of symptoms as the reason they had not been screened; 3) A doctor's recommendation, or lack thereof, significantly influenced patients' decisions to be screened; 4) Patients, but not their physicians, cited fatalistic views about cancer as a barrier. Conversely, physicians identified competing priorities, such as psychosocial stressors or comorbid medical illness, as barriers to screening. In this culturally diverse group of patients seen at community health centers, similar barriers to screening were reported by patients of different backgrounds, but physicians perceived other factors as more important.

Conclusion: Further study of these barriers is warranted.

References

    1. What Are the Key Statistics for Colorectal Cancer?
    1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371. doi: 10.1056/NEJM199305133281901.
    1. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–1575. doi: 10.1093/jnci/84.20.1572.
    1. Selby JV, Friedman GD, Quesenberry CP, Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–657.
    1. Winawer SJ, St John J, Bond J, Hardcastle JD, Kronborg O, Flehinger B, Schottenfeld D, Blinov NN. Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68:505–513.
    1. Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19–26. doi: 10.1097/00008469-200402000-00004.
    1. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of Underutilization of Colorectal Cancer Screening among U.S. Adults, Age 50 Years and Older. Preventive Medicine. 2002;36:85–91. doi: 10.1006/pmed.2002.1127.
    1. Centers for Disease Control and Prevention Trends in screening for colorectal cancer-United States, 1997 and 1999. Morbidity and Mortality Weekly Report. 2001;50:162–166.
    1. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100:2093–2103. doi: 10.1002/cncr.20276.
    1. Walsh JM, Kaplan CP, Nguyen B, Gildengorin G, McPhee SJ, Perez-Stable EJ. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med. 2004;19:156–166. doi: 10.1111/j.1525-1497.2004.30263.x.
    1. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528–1540. doi: 10.1002/cncr.11208.
    1. Walsh JME, Posner SF, Perez-Stable EJ. Colon Cancer Screening in the Ambulatory Setting. Preventive Medicine. 2002;35:209–218. doi: 10.1006/pmed.2002.1059.
    1. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18:1028–1035. doi: 10.1111/j.1525-1497.2003.20807.x.
    1. Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C, Parker R, Patnick J, Moss S. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007;97:1601–1605. doi: 10.1038/sj.bjc.6604089.
    1. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41:23–29. doi: 10.1016/j.ypmed.2004.11.004.
    1. Zimmerman RK, Tabbarah M, Trauth J, Nowalk MP, Ricci EM. Predictors of lower endoscopy use among patients at three inner-city neighborhood health centers. J Urban Health. 2006;83:221–230. doi: 10.1007/s11524-005-9028-z.
    1. Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP. Effects of Health Insurance and Race on Early Detection of Cancer. Journal of the National Cancer Institute. 1999;91:1409–1415. doi: 10.1093/jnci/91.16.1409.
    1. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167:258–264. doi: 10.1001/archinte.167.3.258.
    1. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165:2129–2135. doi: 10.1001/archinte.165.18.2129.
    1. Sheinfeld Gorin S, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med. 2005;40:515–526. doi: 10.1016/j.ypmed.2004.09.031.
    1. Thompson B, Coronado GD, Solomon CC, McClerran DF, Neuhouser ML, Feng Z. Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes Control. 2002;13:719–728. doi: 10.1023/A:1020280427712.
    1. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med. 2003;37:627–634. doi: 10.1016/j.ypmed.2003.09.016.
    1. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable Access to Cancer Services: A Review of Barriers to Quality Care. Cancer. 1999;86:2378–2390. doi: 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>;2-L.
    1. Greiner KA, Born W, Nollen N, Ahluwalia JS. Knowledge and perceptions of colorectal cancer screening among urban African Americans. J Gen Intern Med. 2005;20:977–983. doi: 10.1007/s11606-005-0244-8.
    1. Bastani R, Gallardo N, Maxwell A. Barriers to Colorectal Cancer Screening Among Ethnically Diverse High- and Average-Risk Individuals. Journal of Psychosocial Oncology. 2001;19:65–84. doi: 10.1300/J077v19n03_06.
    1. New Measure, Colorectal Cancer Screening
    1. Crabtree F, Miller W, editor. Doing Qualitative Research.
    1. O'Malley AS, Renteria-Weitzman R, Huerta EE, Mandelblatt J. Patient and provider priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos. Ethn Dis. 2002;12:383–391.
    1. Denzin NK, Lincoln YS, editor. Handbook of Qualitative Research. Vol. 1994. Thousand Oaks, Calif: Sage Publications; 1994. Grounded theory methodology-an overview; pp. 273–285.
    1. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773–1778.
    1. Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001;79:613–639. doi: 10.1111/1468-0009.00223.
    1. Doescher MP, Saver BG, Franks P, Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000;9:1156–1163. doi: 10.1001/archfami.9.10.1156.
    1. Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE, Marcus AC, Steiner JF, Ahnen DJ. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20:989–995. doi: 10.1111/j.1525-1497.2005.00164.x.
    1. Evaluation of the UK Colorectal Cancer Screening Pilot: Final Report
    1. Whynes DK, Frew EJ, Manghan CM, Scholefield JH, Hardcastle JD. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health. 2003;117:389–395. doi: 10.1016/S0033-3506(03)00146-X.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir